Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues

Cancer Research

Volumn 57, Issue 3, 1997, Pages 378-381

  Silva, Ismael D C G ^a   Salicioni, Ana M ^a   Russo, Irma H ^a   Higgy, Nadia A ^a   Gebrim, Luiz H ^b   Russo, Jose ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE;

ARTICLE; BREAST CARCINOGENESIS; CANCER INHIBITION; CELL PROLIFERATION; CHROMOSOME 18Q; DNA DETERMINATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REPRESSOR GENE;

ANTIGENS, CD36; ANTINEOPLASTIC AGENTS, HORMONAL; BASE SEQUENCE; BREAST; BREAST NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; TAMOXIFEN;

EID: 0031043286     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jordan, V. C., and Murphy, C. Endocrine pharmacology of antestrogens as antitumor agents. Endocr. Rev., 11: 578-610, 1990.
2. Katzenellenbogen, B. S. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol. Reprod., 54: 287-293, 1996.
3. Wiseman, H. Tamoxifen. Molecular Basis of Use in Cancer Treatment and Prevention, pp. 147-149, West Sussex, England: John Wiley & Sons, 1994.
4. Le Roy, X., Escot, C., Browllet, J. P., Theillet, C., Maudelonde, T., Simony-Lafontaine, J., Pujol, H., and Rochefort, H. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen treated breast cancer. Oncogene, 6: 431-437, 1991.
5. Maas, R. A., Bruning, P. F., Top, B., Breedijk, A. J., and Peterse, H. L. Growth arrest associated changes of mRNA levels in breast cancer cells measured by semiquantitative RT-PCR: potential early indicators of treatment response. Cancer Lett., 97: 107-116, 1995.
6. Tominaga, T., Yoshida, Y., Matsumoto, A., Hayashi, K., and Kosaki, G. Effects of tamoxifen and derivative (TAT) on cell cycle of MCF-7 in vitro. Anticancer Res., 13: 661-666, 1993.
7. Liang, P., and Pardee, A. B. Differential display of eukaryotic mRNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-971, 1992.
8. Liang, P., Zhu, W., Zhang, X., Guo, Z., O'Connell, R. P., Averbouck, L., Wang, F., and Pardee, A. B. Differential display using one-based anchored oligo-dT primers. Nucleic Acids Res., 22: 5763-5764, 1994.
9. Zhao, S., Ooi, S. L., and Pardee, A. B. New primer strategy improves precision of differential display. Biotechniques, 18: 842-850, 1995.
10. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
11. Greenwald, D. E., Lipski, R. H., Ockenhouse, C. F., Ikeda, H., Tandon, N. N., and Jamieson, G. A. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood, 80: 1105-1115, 1992.
12. Oquendo, P., Hundt, E., Lawler, J., and Seed, B. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell, 58: 95-101, 1992.
13. Vega, M. A., Segui Real, B., Garcia, J. A., Cales, C., Rodrigues, F., Vanderkerckhove, J., and Sandoval, I. V. Cloning, sequencing and expression of cDNA encoding rat LIMP II, a novel 74-kDa lysosomal membrane protein related to the surface protein CD36. J. Biol. Chem., 266: 16818-16824, 1991.
14. Asch, A. S., Liu, I., Bricetti, F. M., Barnwell, J. K., Kwakye-Berko, F., Dokun, A., Goldberger, J., and Pernambuco, M. Analysis of CD36 binding domain ligant specificity controlled by dephosphorylation of an ectodomain. Science (Washington, DC), 262: 1436-1440, 1993.
15. Tandon, N. N., Ockenhouse, C. F., Greco, N. J., and Jamieson, G. A. Adhesive functions of platelets lacking glycoprotein IV (CD36). Blood. 78: 2809-2813, 1991.
16. Armesilla, A., and Vega, M. Structural organization of the gene for human CD36 glycoprotein. J. Biol. Chem., 269: 18985-18991, 1994.
17. Renkawitz, R., Schultz, G., van der Ahe, D., and Bento, M. Sequences in the promoter region of the chicken lysozyme gene required for steroid regulation and receptor binding. Cell, 37: 503-510, 1984.
18. Tuszynski, G. P., Gasic, T. B., Rothman, V. L., Kundsen, K. A., and Gasic, G. J. Thrombospondin, a poteniator of tumor cell metastasis. Cancer Res., 47: 4130-4133, 1987.
19. Nathan, F. E., Hernandes, E., Dunton, C. J., Treat, J., Swintalska, H. I., Joseph, R. R., and Tuszynski, G. P. Plasma thrombospondin levels in patients with gynecologic malignancies. Cancer (Phila.), 73: 2853-2858, 1994.
20. Incardona, F., Lewalle, J. M., Morandi, V., Lambert, S., Legrand, Y., Foidart, J. M., and Legrand, C. Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells. Cancer Res., 73Ian: 166-173, 1995.
21. Qian, X., and Tuszynski, G. P. Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc. Soc. Exp. Biol. Med., 212, 199-206, 1996.
22. Nicholson, A. C., Frida, S., Pearce, A., and Silverstein, R. L. Oxidized LDL binds to the CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler. Thromb. Vasc. Biol., 15: 269-275, 1995.
23. Ross, R. The pathogenesis of artherosclerosis: a perspective for the 1990s. Nature (Lond.), 362: 801-809, 1993.
24. Endeman, G., Stanton, L. W., Madden, K. S., Bryant. C. M., White, R. T., and Prottes, A. A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem., 268: 11811-11816, 1993.
25. Bruning, P. F., Banfrer, J. M. G., Hart, A. A. M., de Jorg-Bakker, M., Linders, D., Van Loor, J., and Nooyen, W. J. Tamoxifen, serum lipoproteins and cardiovascular risk. Br. J. Cancer, 458-497, 1988.
26. McDonald, C. C., and Stewart, H. J. Fatal infarction in the Scottish adjuvant tamoxifen trial. Br. Med. J., 303: 435-437, 1991.
27. Noguchi, K., Naito, M., Tezuka, K., Ishii, S., Seimiya, H., Sugimoto, Y., Amann, E., and Tsuruo, T. cDNA expression cloning of the 85-kDa protein overexpressed in Adriamycin-resistant cells. Biochem. Biophys. Res. Commun., 192: 88-95, 1993.
28. r 170,000 glycoprotein (gp170) binding studies. Cancer Res., 54: 441-447, 1994.